| Literature DB >> 27036540 |
Ke Chen1, Yu Pan1, Jia-Qin Cai1, Di Wu1, Jia-Fei Yan1, Ding-Wei Chen1, Hong-Mei Yu1, Xian-Fa Wang2.
Abstract
BACKGROUND: Laparoscopic-assisted total gastrectomy (LATG) is the most commonly used methods of laparoscopic gastrectomy for upper and middle gastric cancer. However, totally laparoscopic total gastrectomy (TLTG) is unpopular because reconstruction is difficult, especially for the intracorporeal esophagojejunostomy. We adopted TLTG with various types of intracorporeal esophagojejunostomy. In this study, we compared LATG and TLTG to evaluate their outcomes.Entities:
Keywords: Gastric cancer; Intracorporeal anastomosis; Laparoscopy; Meta-analysis; Total gastrectomy
Mesh:
Year: 2016 PMID: 27036540 PMCID: PMC4815120 DOI: 10.1186/s12957-016-0860-2
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Comparison of the clinicopathological characteristics
| LATG ( | TLTG ( |
| ||
|---|---|---|---|---|
| Age (years) | 57.3 ± 12.5 | 59.4 ± 11.1 | 0.18 | |
| Gender | Male | 98 | 73 | 0.99 |
| Female | 47 | 35 | ||
| BMI index (kg/m2) | 23.1 ± 4.2 | 23.5 ± 3.5 | 0.42 | |
| Comorbidity | Absence | 97 | 76 | 0.56 |
| Presence | 48 | 32 | ||
| ASA classification | I | 80 | 65 | 0.60 |
| II | 58 | 37 | ||
| III | 7 | 6 | ||
| Tumor size (cm) | 4.3 ± 2.0 | 4.0 ± 1.8 | 0.23 | |
| Tumor location | Middle | 36 | 33 | 0.31 |
| Upper | 109 | 75 | ||
| Histology | Differentiated | 84 | 67 | 0.51 |
| Undifferentiated | 61 | 41 | ||
| TNM stage | IA/IB | 54/28 | 28/25 | 0.45 |
| IIA/IIB | 18/9 | 14/13 | ||
| IIIA/IIIB/IIIC | 12/10/14 | 13/7/8 |
Comparison of surgical outcomes and postoperative recovery
| LATG ( | TLTG ( |
| |
|---|---|---|---|
| Operation time (min) | 234.8 ± 48.5 | 225.6 ± 52.7 | 0.15 |
| Anastomotic time (min) | 32.8 ± 19.5 | 47.5 ± 23.2 | <0.01 |
| Estimated blood loss (mL) | 137.6 ± 54.7 | 125.3 ± 62.8 | 0.10 |
| Harvested lymph nodes | 31.2 ± 10.4 | 32.8 ± 8.9 | 0.20 |
| Proximal resection margin (cm) | 4.3 ± 1.7 | 4.6 ± 1.6 | 0.16 |
| First flatus (days) | 3.4 ± 1.0 | 3.4 ± 1.1 | 0.19 |
| Diet start time (days) | 4.5 ± 1.3 | 4.4 ± 1.4 | 0.56 |
| Postoperative hospital stay (days) | 9.4 ± 2.5 | 9.2 ± 3.0 | 0.56 |
Comparison of postoperative complications
| LATG ( | TLTG ( |
| |
|---|---|---|---|
| Total complication | 25 | 15 | 0.42 |
| Surgical complications | 20 | 13 | 0.63 |
| Anastomotic leakage | 1 | 1 | |
| Anastomotic stricture | 2 | 3 | |
| Intracorporeal hemorrhage | 1 | 2 | |
| Abdominal abscess | 4 | 1 | |
| Stasis | 3 | 2 | |
| Pancreatic leakage | 2 | 1 | |
| Ileus | 3 | 1 | |
| Lymphorrhea | 1 | 1 | |
| Wound infection | 3 | 1 | |
| Medical complications | 5 | 2 | 0.43 |
| Pulmonary embolism | 0 | 1 | |
| Pulmonary infection | 4 | 1 | |
| Deep venous thrombosis | 1 | 0 |
Characteristics of included studies
| Author | Nation | Study type | Publication year | Study period | Sample size | Quality scores | Details of IE | |
|---|---|---|---|---|---|---|---|---|
| LATG | TLTG | |||||||
| Kim | Korea | Pros | 2013 | 2010–2011 | 23 | 90 | 6 | Functional end-to-end |
| Jung | Korea | Retro | 2013 | 2004–2012 | 47 | 40 | 6 | OrVil™ |
| Ito | Japan | Pros | 2014 | 2001–2012 | 46 | 117 | 6 | OrVil™ |
Retro retrospective observational study, Pros prospective observational study, IE intracorporeal esophagojejunostomy
Pooled short-term outcomes of meta-analysis
| Outcomes | Number of studies | Sample size | Heterogeneity ( | Overall effect size | 95 % CI of overall effect |
| |
|---|---|---|---|---|---|---|---|
| LATG | TLTG | ||||||
| Operation time (min) | 4 | 261 | 355 | 0.06, 59 % | WMD = 11.72 | −2.94~26.38 | 0.12 |
| Anastomotic time (min) | 2 | 192 | 148 | <0.01, 98 % | WMD = −5.36 | −23.29~12.57 | 0.56 |
| Blood loss (ml) | 2 | 191 | 225 | 0.02, 83 % | WMD = 80.39 | −77.33~238.12 | 0.32 |
| Harvested lymph nodes | 3 | 215 | 238 | 0.60, 0 % | WMD = −2.11 | −4.28~0.06 | 0.06 |
| Proximal margin (cm) | 3 | 215 | 238 | 0.26, 26 % | WMD = −0.06 | −0.37~0.26 | 0.73 |
| First flatus (days) | 3 | 215 | 238 | 0.44, 0 % | WMD = −0.01 | −0.19~0.16 | 0.88 |
| Diet start time (days) | 3 | 215 | 238 | 0.12, 53 % | WMD = 0.37 | −0.15~0.90 | 0.17 |
| Hospital stay (days) | 3 | 215 | 238 | 0.63, 0 % | WMD = 0.32 | −0.31~0.96 | 0.32 |
| Overall complications | 2 | 168 | 198 | 0.71, 0 % | RR = 1.31 | 0.78~2.20 | 0.30 |
| Anastomosis-related complications | 4 | 261 | 355 | 0.46, 0 % | RR = 1.26 | 0.60~2.65 | 0.55 |
WMD weighted mean difference, RR risk ratio
Fig. 1Meta-analysis of the pooled data. a Operation time. b Anastomotic time. c Blood loss. d Harvested lymph nodes
Fig. 2a First flatus. b Diet start time. c Hospital stay
Fig. 3a Overall complications. b Anastomosis-related complications
Fig. 4Funnel plot of the anastomosis-related complications